A First-in-Human Single and Multiple Ascending Dose Study of MT-701

NCT07396909 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: MT-701

Sponsor

Mirador Therapeutics, Inc.